Kim, Min Jung
Lee, Dae Won
Kang, Hyun-Cheol
Park, Ji Won
Ryoo, Seung-Bum
Han, Sae-Won
Kim, Kyung Su
Chie, Eui Kyu
Oh, Jae Hwan
Jeong, Woon Kyung
Kim, Byoung Hyuck
Nam, Eun Mi
Jeong, Seung-Yong
Funding for this research was provided by:
Ministry of Health & Welfare, Republic of Korea (HC21C0149, HC21C0149, HC21C0149, HC21C0149, HC21C0149, HC21C0149, HC21C0149, HC21C0149, HC21C0149, HC21C0149, HC21C0149, HC21C0149, HC21C0149)
Article History
Received: 2 July 2023
Accepted: 13 July 2023
First Online: 8 August 2023
Declarations
:
: This study was approved by the Institutional Review Board (IRB) of Seoul National University Hospital, National Cancer Centre, Seoul Metropolitan Government Seoul National University Boramae Medical Centre, Keimyung University Dongsan Medical Centre, and Ewha Womans University Hospital (IRB no.: H-2111–046-1271, NCC2022-0098, 30–2022-20, DSMC2022-01–061, and SEUMC2022-01–028, repectively). Written informed consent will be obtained from all patients for trial participation, data acquisition, and use of clinical data before enrolment. This study was conducted in accordance with the tenets of the Declaration of Helsinki. This study will be monitored by an independent data and safety committee.
: Not applicable.
: There are no competing interests.